These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5922548)

  • 1. Preparation of the vascular permeability factor of Vibrio cholerae.
    Craig JP
    J Bacteriol; 1966 Sep; 92(3):793-5. PubMed ID: 5922548
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholera toxin and toxoid.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    Prog Immunobiol Stand; 1971; 5():348-9. PubMed ID: 4660540
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of type 2 toxins of Vibrio cholerae.
    Lewis AC; Freeman BA
    Science; 1969 Aug; 165(3895):808-9. PubMed ID: 5804723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeability and enterotoxic factors of nonagglutinable vibrios Vibrio alcaligenes and Vibrio parahaemolyticus.
    Bhattacharya S; Bose AK; Ghosh AK
    Appl Microbiol; 1971 Dec; 22(6):1159-61. PubMed ID: 5137585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro production of choleragen and vascular permeability factor by Vibrio cholerae.
    Evans DJ; Richardson SH
    J Bacteriol; 1968 Jul; 96(1):126-30. PubMed ID: 5663564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibrio cholerae: production of toxin by a nonpathogenic strain.
    Blachman U; Basu S; Pickett MJ
    J Infect Dis; 1970 Dec; 122(6):540-3. PubMed ID: 4992340
    [No Abstract]   [Full Text] [Related]  

  • 7. Serological evidence for the identity of the vascular permeability factor and ileal loop toxin of Vibrio cholerae.
    Mosley WH; Aziz KM
    J Infect Dis; 1970 Mar; 121(3):243-50. PubMed ID: 5415045
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing in vitro skin permeability factor production by Vibrio cholerae.
    Richardson SH
    J Bacteriol; 1969 Oct; 100(1):27-34. PubMed ID: 5344097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on cholera toxin and antitoxin.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    J Gen Microbiol; 1970 Nov; 64(1):1-10. PubMed ID: 5516606
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae.
    Sack RB; Carpenter CC
    J Infect Dis; 1969 Feb; 119(2):150-7. PubMed ID: 5776005
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholera toxins: purification and preliminary characterization of ileal loop reactive type 2 toxin.
    Coleman WH; Kaur J; Iwert ME; Kasai GJ; Burrows W
    J Bacteriol; 1968 Oct; 96(4):1137-43. PubMed ID: 4971885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and concentration of V. cholerae toxin and study of its effect on skin permeability in guinea-pigs.
    Bhatia RY; Bhatia AL; Thomas AK
    Indian J Med Res; 1969 Nov; 57(11):2018-29. PubMed ID: 5383748
    [No Abstract]   [Full Text] [Related]  

  • 14. Subunit structure of cholera toxin.
    Lönnroth I; Holmgren J
    J Gen Microbiol; 1973 Jun; 76(2):417-27. PubMed ID: 4198716
    [No Abstract]   [Full Text] [Related]  

  • 15. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.
    Craig JP
    Nature; 1965 Aug; 207(997):614-6. PubMed ID: 5883637
    [No Abstract]   [Full Text] [Related]  

  • 16. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on vaccination against cholera. VI. Toxicity of V. cholerae suspensions killed by various methods.
    Joó I; Pusztai Z; Juhász VP
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):265-76. PubMed ID: 4250052
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium transport inhibition by cholera toxin: the role of non-ionic diffusion of ammonia.
    Grady GF; Madoff MA; Duhamel RC; Moore EW; Chalmers TC
    J Infect Dis; 1968 Jun; 118(3):263-70. PubMed ID: 5668029
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the cholera toxin.
    Ungar J; Chariatte N; Stanić M; Varallyay S
    Prog Immunobiol Stand; 1967; 3():357-62. PubMed ID: 4985515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.